Vertex (VRTX) Must Do Better
Late Tuesday, Vertex Pharmaceuticals (VRTX) revealed the successful results of a couple more of their drug studies. Yesterday, the stock shot up over 20%.This is unacceptable! If I am going to remain an investor in this biotech company, (of which I have had about half of my invested money in for over a year), Vertex (VRTX) must do better!
I don't know if the company is still the number one performing stock of all 500 businesses in the S&P, YTD, as was reported in May. But with a current 2017 gain of about 115%, Vertex (VRTX) is showing some promise. This is not enough!
I want to see a new attitude towards the FDA. Instead of complying with their Phase I, II, & III structure, which basically facilitates super safe drugs so that the companies who are coerced into giving free medicine won't mistakenly dispense harmful substances as free handouts, drug companies should advance research and clinical tests on their own time table, according to their own conscience to advance the company's reputation.
I want to see the acquisition of all FDA applications by those patent holders who had the unpleasant experience of having their drugs shot down. The FDA has been wrong--and, a lot! There are thousands of healing molecules still out their waiting to be commercialized and sold.
I want to see an effort made to completely abolish Government Health Care--which you may note would make my above two FDA reforms obsolete. Vertex (VRTX) wants to make money in the long run. It wants the medical reputation that will facilitate this. Vertex (VRTX) must do better!
Paul Wharton
Objectivist Capitalist Medicine Promoter